Tumors of the Urinary System Flashcards

1
Q

What are the three main goals of surgery as a localized therapy for iUC?

AH

A
  1. Obtain tissue for a definitive diagnosis.
  2. Eradicate lesions amenable to wide excision, such as tumors distant from the trigone.
  3. Relieve urinary tract obstruction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is local recurrence common after partial cystectomy for iUC?

AH

A

field effect
The presence of multifocal lesions suggests a field effect or malignant transformation of the entire urothelium due to carcinogen exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the rate of incontinence after urethral stent placement in dogs?

AH

A

25-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What kind of radiation scheduling is preferred in treatment of iUC based on in vitro studies? (large dose less fractionation or low dose more fractionation?)

AH

A

Higher doses and less fractionation.
Although iUC cells were generally thought to be sensitive, but an in-vitro study suggested moderate radioresistance (low a/b ratio) , supporting higher doses and less fractionation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What were the complications associated with the early use of large doses and less fractionation in radiation therapy?

AH

A

Chronic colitis, cystitis, and urethral strictures, with little improvement in MST compared to medical therapy alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the acute side effects of intensity-modulated and image-guided radiation therapy?

AH

A

Mild and self-limiting, including colitis (38%), erythema or hyperpigmentation (19%), and stranguria (5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the late complications of intensity-modulated and image-guided radiation therapy?

AH

A

Urethral stricture (9%), ureteral stricture (5%), or rectal stricture (5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What were the median event-free survival and overall MST in a series of dogs treated with intensity-modulated and image-guided radiation therapy?

AH

A

Median event-free survival was 317 days, and the overall MST was 654 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What outcomes were reported in a report of dogs with urogenital carcinomas treated with low-dose palliative RT plus antineoplastic drugs?

AH

A

CR or PR in ~60% and SD in ~40% of dogs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is simultaneously combining multiple chemotherapy agents not currently recommended for the treatment of canine iUC?

AH

A

he benefit has not been determined, toxicity is likely to increase, and the potential development of resistance to multiple drugs at the same time could limit the options for subsequent therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Compare MST in dogs receiving vinblastine alone followed by piroxicam alone compared to those receiving both drugs concurrently?

AH

A

The MST was significantly longer in dogs receiving vinblastine alone followed by piroxicam alone (531 days) than in dogs receiving the two drugs given concurrently (299 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a concern with increased use of chlorambucil? for treatment of canine iUC?

AH

A

Chronic myelosuppression persisting for weeks to months has emerged as a concern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What injectable demethylating agent has shown promise in iUC?

AH

A

5-azacitidine, which resulted in PR in 22% and SD in 50% of treated dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What localized drug delivery methods have been used in dogs with iUC?

AH

A

Intravesical mitomycin C and photodynamic therapy (PDT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common form of canine urinary bladder cancer

A

invasive urothelial carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most common location of urothelial carcinoma

A

trigone region of the bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Distant metastatic sites for urothelial carcinoma

A

Lungs (most common), liver, kidney, adrenal gland, spleen, bone, skin, heart, brain, and GI tract

18
Q

Activity of urothelial carcinoma in the abdominal wall

A

Typically aggressive and poorly responsive to medical therapy

19
Q

Risk factors for canine bladder cancer

A

Exposure to older generation flea control products and lawn chemicals, obesity, possibly cyclophosphamide exposure, female gender, and breed-associated risk (Scottish terriers)

20
Q

What factor has been shown to lower the risk for urothelial carcinoma?

A

Dogs that ate vegetables at least three times per week in addition to their dog food

21
Q

TNM Clinical Staging System for Canine Bladder Cancer

A

T - Primary Tumor
- Tis: carcinoma in situ
- T0: No evidence of a primary tumor
- T1: Superficial papillary tumor
- T2: Tumor invading the bladder wall, with induration
- T3: Tumor invading neighboring organs

N - Regional Lymph Node (Internal and External Iliac Lymph Node)
- N0: No regional lymph node involvement
- N1: Regional lymph node involved
- N2: Regional lymph node and juxtaregional lymph node involved

M - Distant Metastases
- M0: No evidence of metastasis
- M1: Distant metastasis present

22
Q

What paraneoplastic syndrome is associated with renal cystadenocarcinoma and uterine tumors in GSDs?

A

nodular dermatofibrosis

23
Q

A mutation in which gene results in nodular dermatofibrosis? Which human syndrome is this similar to?

A

FLCN
Birt-Hogg-Dube syndrome

24
Q

What CBC abnormality may be seen as a paraneoplastic syndrome of renal neoplasia in dogs?

A

Polycythemia

25
Q

What is the MST for renal carcinoma? Renal sarcoma? Nephroblastoma?

A

Renal carcinoma: 6 - 39.5 mos (avg 16 mos)
- 3 mos clear cell
Renal sarcoma: 9 mos
Nephroblastoma: 6 mos

26
Q

What are negative prognostic indicators for RCC?

A

MI
COX-2 expression
Histologic subtype (clear cell)
Furhman nuclear grade

27
Q

What are the MI cutoffs for each grade?

A

1 - <10
2 - 10-30
3 - >30

28
Q

What percentage of canine patients have radiographic evidence of metastasis at diagnosis for RCC?

29
Q

What is the percentage of metastasis noted at time of death for renal sarcoma, nephroblastoma, and carcinoma?

A

Sarcoma - 90% (88)
Nephroblastoma - 75%
Carcinoma - 70% (69)

30
Q

What is the most common presenting complaint for cats with renal carcinoma?

A

Weight loss

31
Q

What are 2 paraneoplastic syndromes described for cats with renal neoplasia?

A

polycythemia
hypertrophic osteopathy (renal adenoma)

32
Q

What is the most common cause of human bladder cancer?

A

Cigarette smoking

33
Q

What percentage of human bladder cancer is invasive urothelial carcinoma?

34
Q

What percentage of human patients have evidence of metastasis for iUC?

35
Q

Which genetic expression alterations are shared between human and canine iUC?

A

COX-2, EGFR, HER2, p53, DNMT1, VIM

36
Q

What is the name of nephroblastoma in human patients?

A

Wilms Tumor

37
Q

What percentage of human adult renal carcinomas are RCC?

38
Q

What are risk factors for RCC in human patients?

A

Cigarette smoking, obesity, hypertension

39
Q

What are common c/s for canine bladder tumors?

A

hematuria, dysuria, pollakiuria, lameness (d/t bone mets/hypertrophic osteopathy, less common) - may resolve temporarily with abx therapy if concurrent UTI

40
Q

How is a definitive diagnosis of iUC made in canines?

A

histopathology

41
Q

IHC for what markers can be used to determine urothelial origin?

A

uroplakin III, +/- GATA-3